InVivo Therapeutics have had promising results using on bipolymer scaffolding to treat spinal cord injury in animal models (See published results). (March 2012: interview with InVivo CEO). Final FDA approval is still required.
Read more
FDA meeting brings promising spinal cord injury treatment closer to human trials
Skip back to main navigation